Tenax Therapeutics, Inc. Ratios

1Y3Y5Y7Y10YAll
Download Data
Ratios Apr2011 Apr2012 Apr2013 Apr2014 Apr2015 Dec2016 Dec2019 Dec2020 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 100.00%13.54%4.16%-39.57%
EBT Margin 10,404.72%-4,297.16%-791.61%-7,157.32%-30,162.37%606,610.76%-248,665.32%32,391.67%76,534.78%
EBIT Margin 10,238.43%-2,259.66%-435.71%-6,316.14%-30,062.78%606,510.76%-248,765.32%34,308.33%84,756.52%
EBITDA Margin 10,238.43%-2,259.66%-435.71%7,430.50%28,517.42%-605,526.67%-248,658.45%-32,127.80%84,756.52%
Operating Margin 10,238.43%-2,259.66%-435.71%-6,316.14%-30,062.78%606,510.76%-248,765.32%34,308.33%84,756.52%
Net Margin 10,404.72%4,319.19%871.07%9,637.14%28,571.63%606,610.76%-248,665.32%32,391.67%76,534.78%
FCF Margin -8,378.62%-2,280.50%-414.68%-3,525.30%-19,788.64%570,150.34%256,326.15%24,600.00%64,395.65%
Efficiency
Inventory Average 0.17M0.09M
Assets Average 3.53M3.66M
Equity Average -2.04M-1.06M40.54M76.64M43.78M
Invested Capital -3.72M-0.35M-1.78M82.86M70.43M17.14M
Asset Utilization Ratio 0.100.33
Leverage & Solvency
Interest Coverage Ratio -61.57-1.11-1.22-7.51-301.88-0.01M0.00M-343.08-847.57
Debt to Equity -1.20-3.93-1.68
Debt Ratio 1.530.330.94
Equity Ratio -1.27-0.08-0.560.73
Times Interest Earned -61.57-1.11-1.22-7.51-301.88-0.01M0.00M-343.08-847.57
Valuation
Enterprise Value 40.51M49.73M6.08M25.38M88.27M41.57M9.51M23.47M4.98M6.55M24.85M
Market Capitalization 41.46M51.61M6.86M83.70M96.20M54.85M9.51M23.47M4.98M6.55M24.85M
Return Ratios
Return on Sales 104.05%-42.97%-7.92%-71.57%-301.62%323.92%765.35%
Return on Capital Employed -20.28%-2.96%
Return on Invested Capital -1.02%
Return on Assets -4.43%-2.57%
Return on Equity 7.68%8.88%-0.46%-0.19%-1.02%